Altitude sickness epidemiology and demographics: Difference between revisions
m (Categories) |
|||
| Line 4: | Line 4: | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | ||
==Overview== | ==Overview== | ||
With a rapid ascension to high altitudes in 1 to 3 days, more than 50% of people develop altitude sickness. The incidence of clinical HAPE in unacclimatized travelers exposed to high altitude (~ 4,000 m) appears to be less than 1%. In over 30 years of research experience, the [[United States Army Pike’s Peak Research Laboratory|U.S. Army Pike's Peak Research Laboratory]], utilizing about 300 sea-level resident volunteers (and more than 100 staff members) rapidly and directly exposed to high altitude, only 3 were evacuated with suspected HAPE. | With a rapid ascension to high altitudes in 1 to 3 days, more than 50% of people develop altitude sickness. The incidence of clinical HAPE in unacclimatized travelers exposed to high altitude (~ 4,000 m) appears to be less than 1%. In over 30 years of research experience, the [[United States Army Pike’s Peak Research Laboratory|U.S. Army Pike's Peak Research Laboratory]], utilizing about 300 sea-level resident volunteers (and more than 100 staff members) rapidly and directly exposed to high altitude, only 3 were evacuated with suspected HAPE. | ||
==Epidemiology and Demographics== | |||
==References== | ==References== | ||
{{reflist|2}} | |||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
{{WH}} | |||
{{WS}} | |||
Revision as of 19:01, 8 June 2016
|
Altitude sickness Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Altitude sickness epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Altitude sickness epidemiology and demographics |
|
Risk calculators and risk factors for Altitude sickness epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
With a rapid ascension to high altitudes in 1 to 3 days, more than 50% of people develop altitude sickness. The incidence of clinical HAPE in unacclimatized travelers exposed to high altitude (~ 4,000 m) appears to be less than 1%. In over 30 years of research experience, the U.S. Army Pike's Peak Research Laboratory, utilizing about 300 sea-level resident volunteers (and more than 100 staff members) rapidly and directly exposed to high altitude, only 3 were evacuated with suspected HAPE.